About Radiant Medical
Radiant Medical is the leading developer and manufacturer of state-of-the-art endovascular temperature therapy systems. Potential applications include endovascular cooling for myocardial infarction (heart attack), ischemic stroke (brain attack), cardiac arrest, and temperature management of patients in surgery and critical care. Radiant Medical's enabling platform technology can be applied in a variety of clinical settings for multiple medical indications where cooling or warming is required.
Missing: Radiant Medical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Radiant Medical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Radiant Medical Patents
Radiant Medical has filed 2 patents.
Fluid dynamics, Medical equipment, Circadian rhythm, Sleep, Thermoregulation
Fluid dynamics, Medical equipment, Circadian rhythm, Sleep, Thermoregulation
Latest Radiant Medical News
Aug 16, 2021
'MyCare Medical Group' Enters Into Strategic Partnership With 'Medical Group Of South Florida' And 'Radiant Medical Group' TAMPA, Fla., Aug. Aug 16, 2021 10:56 AM EDT TAMPA, Fla., Aug. 16, 2021 /PRNewswire/ -- MyCare Medical Group officially announced it had entered into a partnership and full merger with both Medical Group of South Florida (MGSFL) and Radiant Medical Group. Marking another key milestone of continued growth, the merger allows MyCare to expand into Palm Beach County where MGSFL and Radiant are based. MyCare will also now offer cardiology, chiropractic, endocrinology, gastroenterology, orthopedics, physical therapy, podiatry, along with imaging and radiology oncology services through MGSFL's multidisciplinary approach. Specializing in older adult care, MyCare serves over 100,000 patients in Florida, with approximately 30,000 Medicare Advantage patients and 10,000 traditional Medicare patients. "It was wonderful to find a partner that shares our same passion for providing exceptional patient care through a team-based approach," said Dr. Joshua Smith, MGSFL and Radiant Founder. "I look forward to our continued growth with MyCare and the positive impact this merger will have on our patients and the communities we serve." "The addition of Medical Group of South Florida and Radiant brings the leading provider group in Palm Beach County for primary care and multi-specialty services to the MyCare Medical platform," said Gautam Shirhattikar, CEO of MyCare Medical Group. "Dr. Josh Smith and his team have done phenomenal work in providing a one-stop-shop to patients which addresses their entire health. We are excited about leveraging this new dimension of patient services across MyCare." Founded in 2000, MGSFL has served the Palm Beach area for over 20 years with over 30 healthcare professionals, including both primary care providers and specialty physicians. MGSFL has always worked to fulfill its core mission of providing a meaningful and positive impact to the senior community. Founded in 2018, Radiant Medical Group is a Medicare Advantage management services organization with over 80 affiliate group practices and 200 providers. For the latest updates on the growing MyCare family of healthcare providers, or to learn more about its services, visit them online . And follow MyCare on social media: Facebook . About MyCare Medical Formed in 2018, MyCare Medical Group is a primary care group whose physicians have been providing high quality patient care in a value-based model to Central and South Florida for more than 35 years. MyCare was founded by physicians that are committed to delivering the best possible patient outcomes and specialize in caring for and maintaining the health of older adults - helping them to live lives as healthy, active seniors. MyCare's provider network currently has over 100 practitioners and specialists working throughout multiple counties in Florida. Learn more at: www.MyCareMedicalGroup.com . Media Contacts: View original content: https://www.prnewswire.com/news-releases/mycare-medical-group-enters-into-strategic-partnership-with-medical-group-of-south-florida-and-radiant-medical-group-301355938.html
Radiant Medical Frequently Asked Questions (FAQ)
When was Radiant Medical founded?
Radiant Medical was founded in 1997.
Where is Radiant Medical's headquarters?
Radiant Medical's headquarters is located at 250 Chesapeake Drive, Redwood City.
What is Radiant Medical's latest funding round?
Radiant Medical's latest funding round is Asset Sale.
How much did Radiant Medical raise?
Radiant Medical raised a total of $102.18M.
Who are the investors of Radiant Medical?
Investors of Radiant Medical include ZOLL, InterWest Partners, Lightspeed Venture Partners, Alta Partners, Three Arch Partners and 7 more.
Who are Radiant Medical's competitors?
Competitors of Radiant Medical include NeoChord, Angel Medical Systems, Spectrum Medical, USGI Medical, AngioScore and 16 more.
Compare Radiant Medical to Competitors
NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.
OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.
NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.
IntraOp Medical Corporation provides ] technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer IOERT safely and effectively for all cancer patients. The Mobetron is the first IOERT device designed for use in existing operating rooms and has been used to treat over 20 different cancer indications. Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and happier patients with fewer side effects. Leading hospitals and clinics throughout the world use the Mobetron as a vital part of their comprehensive cancer program.
Minrad, Inc. is a manufacturer of generic inhalation anesthetics
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.